Navigation Links
Low immunity in people with multiple sclerosis may be genetical

People who have low immunity that had lead to inability to curbing of inflammatory cells// and cause multiple sclerosis may have genes that act likewise. Researchers from Oregon Health & Science University have reported that the FOXP3 gene may be responsible for the low immune problem that leads to progress of multiple sclerosis.

Multiple sclerosis is a chronic neurological disease of the central nervous system. There is no cure for this disease but modern day treatment may slow the course of development or give relief from some of the symptoms of this disease.

Researchers are of opinion that FOXP3 gene, found in the subset of T-cells, regulates the immunity of the body against multiple sclerosis and other autoimmune diseases like diabetes and arthritis. This is the first study that establishes an association between multiple sclerosis and the FOXP3 gene. The research suggests that lower expression of the FOXP3 gene suppresses the functions of the regulatory T cells. This leads to the body’s inability to control the inflammatory cells that in turn attack the nerve fibers. This leads to the increased incidence of multiple sclerosis disease on people.

Reference: Journal of Neuroscience Research, July 2005
'"/>




Page: 1

Related medicine news :

1. Stress reduces your immunity- startling but true!!!!!
2. Omega-3 fatty acids impair immunity
3. Severe stress weakens immunity
4. Parasitic infections and human immunity link found
5. Human immunity system can battle HIV.
6. Cholesterol provides immunity against infection by certain parasites
7. Mix and match of proteins may have a significant role in immunity
8. Antioxidants protect health tissue in people undergoing radiation therapy.
9. Skinny people need to exercise too
10. Hormone treatment helps obese people slim down
11. Safe for people with asthma

Post Your Comments:
(Date:11/27/2009)...UILLY-SUR-SEINE,France,Nov.27/PRNewswire/--TeamGar...teamdedicatedtoethicalsportinganddevelopingthenext...illbecomeTeamGarmin-TransitionswiththeadditionofTr...Opticalistheworld,sleadingmanufacturerofadaptiveey...yinthewidestselectionofspectaclelensessuchasTransi...
(Date:11/27/2009)...tes to bring unprecedented medical, economic burde...HealthDay News) -- The number of people with diabe...r the next 25 years, a new study predicts. , Th...lion people with the disease, up from 23.7 million...ng people with diabetes will triple, the study als...
(Date:11/27/2009)... Specialist manufacturers who use m...re saving millions of dollars by bringing in techn... Increasing numbers of pro-active medical manufact...the concept stage of their projects, ensuring that...gn processes or potentially outdated technology. ...
(Date:11/26/2009)...ext 25 years, the number of Americans living with ...million in 2009 to 44.1 million in 2034. Over the ...le, rising from $113 billion to $336 billion, even...searchers based at the University of Chicago repor...e number of those with diabetes covered by Medicar...
(Date:11/26/2009)... No more letters from the North Pol...ized text messages from Santa , ...ncrease operational efficiencies at the North Pole...keep children all over the globe informed of his C...Santa’s research department have identified ...
Breaking Medicine News(10 mins):Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2
... NCCN names Cold Spring Publishing, LLC, as the ne...e National Comprehensive Cancer Network. Cold Spri... company led by Jack Gentile, founder of PRR, Inc....y(TM). , , FORT WASHINGTON, Pa., Feb. 10 JNCCN ...
...China, Feb. 10 /PRNewswire-Asia-FirstCall/ -- Chin...r ,the Company,) (Nasdaq: CSKI ), a,leading full...-the-counter,drugs in the People,s Republic of Chi...ibution from its recent,acquisitions, the Company ...
...led 2.7 million prescriptions through AZ&Me(TM...el., Feb. 10 AstraZeneca (NYSE: AZN ) announc...s to 440,541 patients in the United States last ye...neca is committed to helping patients who are faci...
...b. 10 HMS (Nasdaq: HMSY ) today announced that ...m Neighborhood Health Providers and Optima Health,... lives to its managed care portfolio. HMS will pro...coverage not previously known for its Medicaid mem...
...ems to reduce the risk of cognitive impairment, de...s) -- Chalk up another endorsement for the so-call...s rich in fruits, vegetables, fish and olive oil, ... -- marked by forgetfulness and difficulty concent...
...Calif., Feb. 10 Firefighter and wife help others ... Veteran firefighter Bryan Russell, from the "OC,"...nnifer found the hero in her life when she met fir...e asks, "Do you know any single people?" In Jenn a...
Other Medicine News:Health News:JNCCN Names New Publishing Company 2Health News:JNCCN Names New Publishing Company 3Health News:China Sky One Medical, Inc. Reaffirms Guidance for 2008 Revenue and Net Income and Provides Business Update 2Health News:China Sky One Medical, Inc. Reaffirms Guidance for 2008 Revenue and Net Income and Provides Business Update 3Health News:AstraZeneca Helped More Than 440,000 Patients Save $612 Million on Medicines in 2008 2Health News:HMS Awarded New Contracts for Managed Care Services 2Health News:Mediterranean Diet Aids the Aging Brain: Study 2Health News:Mediterranean Diet Aids the Aging Brain: Study 3Health News:Heroes Find Love, Love Finds Heroes 2
(Date:11/27/2009)...LTLAKECITY,Nov.27/PRNewswire-FirstCall/--Booth-364...,apremiersupplierofX-raytubesandflatpaneldigitalim...heRSNAAnnualMeetinginChicago,Ill.fromNovember29-De...chnologyformultiplemodalitiesaswellasspecializedca...llshowcasethelatestX-raytechnologyincluding: ,,...
(Date:11/25/2009)...NOGAPARK,Calif.,Nov.25/PRNewswire/--PraxisElectron...ricanAcademyofFamilyPhysicians,(AAFP)FamilyPractic...provingmedicalquality,healthmaintenance,anddisease...n.Praxisalsoranked#1amongdoctorsindicatingtheirEMR...,Praxisalsorankednumberoneinthecountryinprovidinge...
(Date:11/25/2009)...INCETON,N.J.,Nov.25/PRNewswire-FirstCall/--Pharmas...alcompanycommittedtodiscovering,developingandcomme...dfinancialresultsforthefiscalyearendedSeptember30,...ncash,cashequivalentsandshortterminvestments. ,... ,, Phase2bTrial ,, InlateNovember2009,a...
Breaking Medicine Technology:Varian Medical Systems to Highlight the Latest Digital Detectors, X-ray Tubes and Cancer Treatment Technology at the Radiological Society of North America (RSNA) Annual Meeting in Chicago 2Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Scientists Spot Clue to Cancers Aggressiveness 56441 1Lapatinib shows minimal effect against liver cancer 56439 1Lapatinib shows minimal effect against liver cancer 56439 2Lapatinib shows minimal effect against liver cancer 56439 3Team reveals molecular mechanism underlying a form of diabetes 56437 1Team reveals molecular mechanism underlying a form of diabetes 56437 2
...armaceuticals, a privately-held biopharmaceutical ...ollment in the Company,s second pivotal Phase 3 cl... Together with the previously completed first pivo... fully enrolled its planned pivotal Phase 3 studie...e oral therapy currently in development for the tr...
...ut tumor growth and reduced the risk of disease pr... , - Only once-daily oral cancer treatment to dire...ontrols tumor cell division and blood vessel growt...ntial of Afinitor in multiple additional cancers ,...ed today that Afinitor(R) (everolimus) tablets has...
Other Medicine Technology:QuatRx Completes Enrollment of Ophena(TM)(Ospemifene Tablets) Final Pivotal Phase 3 Study in Women with Postmenopausal Vaginal Atrophy 2QuatRx Completes Enrollment of Ophena(TM)(Ospemifene Tablets) Final Pivotal Phase 3 Study in Women with Postmenopausal Vaginal Atrophy 3Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib 2Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib 3Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib 4Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib 5Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib 6Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib 7Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib 8
Urocare® Latex Urinary Leg Bag - Short-Wide
Urocare® Latex Urinary Leg Bag - Large
Medtronic Resting Heart™ System
DLP Recirculation Adapter, Y-Type
Medicine Products: